Oksana Shlobin, MD, FCCP

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Consulting Fee
    Ineligible company:
    Bayer
    Topic:
    CTEPH
    Date added:
    04/12/2023
    Date updated:
    09/21/2024
    Relationship end date:
    12/31/2023
  • Attribution:
    Self
    Type of financial relationship:
    Consulting Fee
    Ineligible company:
    United Therapeutics
    Topic:
    PH
    Date added:
    07/13/2023
    Date updated:
    09/21/2024
    Relationship end date:
    12/31/2023
  • Attribution:
    Self
    Type of financial relationship:
    Consulting Fee
    Ineligible company:
    Janssen
    Topic:
    PH
    Date added:
    07/13/2023
    Date updated:
    09/21/2024
    Relationship end date:
    12/31/2023
Return to 2024 Inova Fairfax MGR (Enduring Material): What’s new in the world of PH?